GlaxoSmithkline Consumer Healthcare has informed that in accordance with the Company’s Policy on Insider Trading, the date of commencement of closing of ‘Trading Window’ shall be from June 24, 2016 and shall end 24 hours after declaration of Audited / Unaudited Financial Results for the Quarter ending June 30, 2016.
The above information is a part of company’s filings submitted to BSE.